Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Long-Term Debt Repayments (2016)

Historic Long-Term Debt Repayments for United Therapeutics (UTHR) over the last 2 years, with Q3 2016 value amounting to $900000.0.

  • United Therapeutics' Long-Term Debt Repayments fell 6785.71% to $900000.0 in Q3 2016 from the same period last year, while for Dec 2016 it was $8.8 million, marking a year-over-year decrease of 9339.34%. This contributed to the annual value of $8.8 million for FY2016, which is 9339.34% down from last year.
  • Per United Therapeutics' latest filing, its Long-Term Debt Repayments stood at $900000.0 for Q3 2016, which was down 6785.71% from $7.8 million recorded in Q2 2016.
  • United Therapeutics' 5-year Long-Term Debt Repayments high stood at $90.3 million for Q2 2015, and its period low was $100000.0 during Q1 2016.